Literature DB >> 22092132

Neurally adjusted ventilatory assist vs. pressure support ventilation in critically ill patients: an observational study.

J Barwing1, N Linden, M Ambold, M Quintel, O Moerer.   

Abstract

BACKGROUND: During neurally adjusted ventilatory assist (NAVA), the inspiratory support is controlled by the patients' respiratory drive influenced by an operator-controlled gain factor (NAVA level). The purpose of our observational study was to transfer patients from conventional pressure support ventilation (PSV) to NAVA safely. We compared two approaches to set the NAVA level and evaluated the effect of NAVA.
METHODS: We studied mechanically ventilated patients capable of spontaneous breathing. For the change of the ventilator mode, we used a NAVA level calculated to generate a peak inspiratory pressure equal to PSV. We compared this NAVA level with a NAVA level determined by a NAVA level titration. Ventilatory and haemodynamic data were recorded during an observational period of 6 h.
RESULTS: All 20 patients included in the study could be transferred from PSV to NAVA and completed the observation interval. Setting the NAVA level according to prior PSV settings proved to be a feasible approach, but in 75% of our patients, we modified the NAVA level according to the titration results. Gas exchange and ventilatory mechanics during the observation interval remained stable.
CONCLUSIONS: The ventilator mode NAVA seems to be well tolerated in a heterogeneous group of critically ill patients. Pre-setting of the NAVA level during PSV can result in an overestimation of the required ventilator support. An additional titration of the NAVA level ads valuable information although difficult to interpret in some cases.
© 2011 The Authors. Acta Anaesthesiologica Scandinavica © 2011 The Acta Anaesthesiologica Scandinavica Foundation.

Entities:  

Mesh:

Year:  2011        PMID: 22092132     DOI: 10.1111/j.1399-6576.2011.02522.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

1.  NAVA enhances tidal volume and diaphragmatic electro-myographic activity matching: a Range90 analysis of supply and demand.

Authors:  Katherine T Moorhead; Lise Piquilloud; Bernard Lambermont; Jean Roeseler; Yeong Shiong Chiew; J Geoffrey Chase; Jean-Pierre Revelly; Emilie Bialais; Didier Tassaux; Pierre-François Laterre; Philippe Jolliet; Thierry Sottiaux; Thomas Desaive
Journal:  J Clin Monit Comput       Date:  2012-09-27       Impact factor: 2.502

2.  Inappropriate use of neurally adjusted ventilator assist.

Authors:  Francesca Iodice; Giuseppina Testa; Antonio Amodeo; Paola Cogo
Journal:  BMJ Case Rep       Date:  2012-09-03

Review 3.  Clinical review: Update on neurally adjusted ventilatory assist--report of a round-table conference.

Authors:  Nicolas Terzi; Lise Piquilloud; Hadrien Rozé; Alain Mercat; Frédéric Lofaso; Stéphane Delisle; Philippe Jolliet; Thierry Sottiaux; Didier Tassaux; Jean Roesler; Alexandre Demoule; Samir Jaber; Jordi Mancebo; Laurent Brochard; Jean-Christophe Marie Richard
Journal:  Crit Care       Date:  2012-06-20       Impact factor: 9.097

4.  Effects of Neurally Adjusted Ventilatory Assist (NAVA) levels in non-invasive ventilated patients: titrating NAVA levels with electric diaphragmatic activity and tidal volume matching.

Authors:  Yeong Shiong Chiew; J Geoffrey Chase; Bernard Lambermont; Jean Roeseler; Christopher Pretty; Emilie Bialais; Thierry Sottiaux; Thomas Desaive
Journal:  Biomed Eng Online       Date:  2013-07-02       Impact factor: 2.819

Review 5.  Neurally adjusted ventilatory assist.

Authors:  Paolo Navalesi; Federico Longhini
Journal:  Curr Opin Crit Care       Date:  2015-02       Impact factor: 3.687

Review 6.  Proportional modes of ventilation: technology to assist physiology.

Authors:  Annemijn H Jonkman; Michela Rauseo; Guillaume Carteaux; Irene Telias; Michael C Sklar; Leo Heunks; Laurent J Brochard
Journal:  Intensive Care Med       Date:  2020-08-11       Impact factor: 17.440

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.